Edition:
United Kingdom

Mithra Announces Valorization Of French Subsidiary


Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Mithra Pharmaceuticals Sa ::MITHRA ANNOUNCES VALORIZATION OF FRENCH SUBSIDIARY.SUCCESSFULLY DIVESTED ITS FRENCH AFFILIATE, MITHRA FRANCE‍​.SALE CONSISTS OF TWO AGREEMENTS.FIRST CONTRACT IS CLOSED WITH LABORATOIRE CCD.ON CONTRACT LABORATOIRE CCD: CONCERNS TRANSFER OF MARKETING AUTHORIZATIONS FOR 4 PRODUCTS.LABORATOIRE CCD CONTRACT: HAS 10-YEAR EXCLUSIVE TIBELIA LICENSE&SUPPLY AGREEMENT IN FRANCE.LABORATOIRE CCD CONTRACT: MITHRA ELIGIBLE FOR UPFRONT PAYMENT AND FUTURE ROYALTIES FOR 4 PRODUCTS OVER 5 YRS.COMMERCIAL LAUNCH OF TIBELIA IN FRANCE IS EXPECTED IN H2 2018.OTHER CONTRACT: SHARE PURCHASE AGREEMENT FOR MITHRA FRANCE WITH THERAMEX.THERAMEX WILL TAKE OVER SUBSIDIARY INCLUDING ITS PHARMACEUTICAL LICENSE.FINANCIAL DETAILS OF AGREEMENTS WERE NOT DISCLOSED.